Desjardins Global Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $767K | Sell |
873
-482
| -36% | -$423K | 0.08% | 202 |
|
|
2023
Q3 | $1.12M | Sell |
1,355
-871
| -39% | -$717K | 0.12% | 168 |
|
|
2023
Q2 | $1.6M | Sell |
2,226
-520
| -19% | -$374K | 0.18% | 131 |
|
|
2023
Q1 | $2.26M | Sell |
2,746
-1,003
| -27% | -$824K | 0.28% | 70 |
|
|
2022
Q4 | $2.7M | Sell |
3,749
-1,118
| -23% | -$806K | 0.43% | 39 |
|
|
2022
Q3 | $3.35M | Buy |
4,867
+11
| +0.2% | +$7.58K | 0.42% | 37 |
|
|
2022
Q2 | $2.87M | Sell |
4,856
-905
| -16% | -$535K | 0.38% | 57 |
|
|
2022
Q1 | $4.02M | Sell |
5,761
-3,643
| -39% | -$2.54M | 0.35% | 57 |
|
|
2021
Q4 | $5.94M | Buy |
+9,404
| New | +$5.94M | 0.51% | 47 |
|